Literature DB >> 1280576

Management of insulin-dependent diabetes mellitus.

D M Nathan1.   

Abstract

Insulin therapy has been lifesaving for patients with insulin-dependent diabetes mellitus. Unfortunately, longer lifespan has unmasked microvascular, neurological and macrovascular complications that result in profound morbidity and increased mortality. Driven by the conviction that better physiological control of glycaemic levels will prevent and/or ameliorate long term complications, and by the desire to make diabetes care as user-friendly as possible, clinical research efforts have led to the development of new treatment methods with the aim of achieving near normal metabolic control. Such methods include the use of self monitoring, multiple daily insulin injection regimens, external and implantable insulin pumps, and whole organ pancreas and isolated islet cell transplantation. In addition, dietary manipulation, including the use of alpha-glucosidase inhibitors, has played a role in controlling glycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280576     DOI: 10.2165/00003495-199200443-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  52 in total

1.  Clinical evaluation of vascular damage in diabetes mellitus.

Authors:  H DOLGER
Journal:  J Am Med Assoc       Date:  1947-08-16

2.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

3.  Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

Authors:  J A Galloway; C T Spradlin; R L Nelson; S M Wentworth; J A Davidson; J L Swarner
Journal:  Diabetes Care       Date:  1981 May-Jun       Impact factor: 19.112

4.  Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.

Authors:  G Dimitriadis; E Hatziagellaki; E Alexopoulos; O Kordonouri; V Komesidou; M Ganotakis; S Raptis
Journal:  Diabetes Care       Date:  1991-05       Impact factor: 19.112

5.  Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy.

Authors:  P Reichard; U Rosenqvist
Journal:  J Intern Med       Date:  1989-08       Impact factor: 8.989

6.  Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.

Authors:  G Dimitriadis; P Tessari; V Go; J Gerich
Journal:  Metabolism       Date:  1982-08       Impact factor: 8.694

7.  Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day.

Authors:  P O Olsson; H Arnqvist; H von Schenck
Journal:  Acta Med Scand       Date:  1986

8.  Efficacy of home glucose monitoring in diabetic pregnancy.

Authors:  M W Varner
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

9.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

10.  alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.

Authors:  G D Dimitriadis; P Tessari; V L Go; J E Gerich
Journal:  Metabolism       Date:  1985-03       Impact factor: 8.694

View more
  1 in total

1.  Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation.

Authors:  David M Salvay; Christopher B Rives; Xiaomin Zhang; Fei Chen; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Transplantation       Date:  2008-05-27       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.